Thermo Fisher Q2 revenue $10.69B (-3% YoY), GAAP EPS $3.51, cuts FY guidance

THERMO FISHER SCIENTIFIC INC.

2023-Q2 EPS reported $6.83 revenue$21,397,000,000

Q2 revenue $10.69B, down 3% YoY; core organic growth +2%; COVID testing revenue $0.08B.
GAAP diluted EPS $3.51 (vs $4.22 YoY); adjusted EPS $5.15 (vs $5.51 YoY).
FY 2023 guidance revised: revenue $43.4-44.0B, core organic growth 2-4%, adj. EPS $22.28-22.72.
Announced agreement to acquire CorEvitas for ~$0.9B post-quarter; adds real-world evidence solutions.
CEO cites challenging macro, slower China spend; PPI Business System helping navigate environment.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

THERMO FISHER SCIENTIFIC INC. reported the fiscal quarter ended July 1, 2023 results: revenue $10.69 billion, EPS $3.51. Guidance lowered.

Period: the fiscal quarter ended July 1, 2023
Revenue: $10.69 billion
EPS: $3.51
Guidance: lowered
Result: reported results

Exact text from the filing

the world leader in serving science, today reported its financial results for the second quarter ended July 1, 2023. Second Quarter 2023 Highlights • Second quarter revenue was $10.69 billion, 3% lower versus the same quarter last year. Core organic revenue growth was 2%. • Second quarter GAAP diluted earnings per share (EPS) was $3.51. • Second quarter adjusted EPS

View on SEC.gov

6 earnings releases filed in the last 30 days. Browse all earnings releases →

THERMO FISHER SCIENTIFIC INC. filing history →

Source: SEC EDGAR

accession 0000097745-23-000054

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.